Tsveta Milanova - Net Worth and Insider Trading
Tsveta Milanova Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Tsveta Milanova owns 1 companies in total, including Agios Pharmaceuticals Inc (AGIO) .
Click here to see the complete history of Tsveta Milanova’s form 4 insider trades.
Insider Ownership Summary of Tsveta Milanova
|Ticker||Comapny||Transaction Date||Type of Owner|
|AGIO||Agios Pharmaceuticals Inc||2023-01-03||Chief Commercial Officer|
Tsveta Milanova Trading Performance
Tsveta Milanova Ownership Network
Ownership Network List of Tsveta Milanova
Ownership Network Relation of Tsveta Milanova
Tsveta Milanova Owned Company Details
What does Agios Pharmaceuticals Inc do?
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development strategy for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
Who are the key executives at Agios Pharmaceuticals Inc?
Tsveta Milanova is the Chief Commercial Officer of Agios Pharmaceuticals Inc. Other key executives at Agios Pharmaceuticals Inc include Chief Financial Officer Cecilia Jones , director & Chief Executive Officer Brian Goff , and Chief Legal Officer James William Burns .
Agios Pharmaceuticals Inc (AGIO) Insider Trades Summary
Over the past 18 months, Tsveta Milanova made no insider transaction in Agios Pharmaceuticals Inc (AGIO). Other recent insider transactions involving Agios Pharmaceuticals Inc (AGIO) include a net sale of 100,000 shares made by David P Schenkein , and a net sale of 1,582 shares made by Washburn Theodore James Jr. .
In summary, during the past 3 months, insiders sold 100,737 shares of Agios Pharmaceuticals Inc (AGIO) in total and bought 0 shares, with a net sale of 100,737 shares. During the past 18 months, 101,582 shares of Agios Pharmaceuticals Inc (AGIO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 101,582 shares.
Agios Pharmaceuticals Inc (AGIO)'s detailed insider trading history can be found in Insider Trading Tracker table.
NAS:AGIO Insider Transactions
Tsveta Milanova Mailing Address
Above is the net worth, insider trading, and ownership report for Tsveta Milanova. You might contact Tsveta Milanova via mailing address: C/o Agios Pharmaceuticals, Inc., 88 Sidney Sreet, Cambridge Ma 02139.